Home Services Kiliminjaro Investments
Kiliminjaro Investments PDF Print E-mail


Pharmed continues to hold a 54.64% interest in this property owning company. The company achieved a 5.88% increase in attributable earnings and has paid out an interim and annual dividend amounting to R3.40 cents a share.